1.11 Group

06/24/2025

In the first full episode of Healthcare Marketing Sherpas, host Janet Carlson interviews Steve Woodruff, President of Clarity Fuel and rabid Voxxie™ champion.

06/10/2025

This is the introductory episode of Healthcare Marketing Sherpas, hosted by Janet Carlson, CEO of the 1.11 Group.

12/10/2024

We've been revamping our messaging to get our ducks in a row for end of year, launching into 2025:

WE ARE YOUR HEALTHCARE MARKETING SHERPAS*.

We'll start with a plan, then build your strategies + tactics in days using our AI-powered tools. It's a streamlined process that is flexible, fast and fun.

*We can guide you or carry you. You choose.

Visit our revamped website too:

Working to improve patient health one lab at a time. Omics Lab Solutions not only sets the standard for excellence in laboratory consulting, but also creates a lasting impact on the health and well-being of patients.

10/02/2024

Our daughter Ellie is doing a fundraiser for Connecticut Children’s Hospital! It’s part of HuskyTHON, where 4,400 UConn kids dance in a marathon to raise money…this event has raised over $13 million in 25 years! Ellie has been a patient at Connecticut Children’s Hospital for knee surgery and she received top notch care. Donate what you can to this amazing cause—-her goal is to raise $250.00.

A fundraising page for Ellie Sanders

03/28/2024

I’m on a rare disease journey, and not only because of my career. It’s a personal odyssey tracing back to the very roots of my family tree. It’s woven into the fabric of my earliest memories and my personal aspirations. ​​​​​​​​​

It began during a mundane morning routine with one of my brothers. Amidst the simplicity of brushing our teeth, I noticed his lack of development. Why, I wondered? That puzzle lingered in my mind until a Franklin College genetics class illuminated the mystery: Klinefelter Syndrome. This reshaped my brother’s life. It allowed him to embrace his strengths and build a beautiful family through adoption. It also redirected the course of my own life.

I veered away from medical school—a decision my family hasn’t let me forget— and found my calling in the pharmaceutical world. However, it wasn’t until after my tenure at Pfizer that I found my niche in medical advertising on Madison Avenue. I thrived there, crafting narratives for healthcare professionals and consumers that would improve patient health globally. Launching my own ad agency allowed me, with my team, to work on many different drugs and diseases. That’s where work on conditions like narcolepsy, Acquired hemophilia A (AHA), and rare cancers further fueled my passion for healthcare.

As research produced solutions for people with rare diseases, we were there to help. We delved into the complexities of conditions like Spinal Muscular Atrophy (SMA), Paroxysmal Nocturnal Hemoglobinuria (PNH), Transthyretin Amyloidosis (ATTR), and novel treatments for rare cancers. We learned to illuminate the intricacies of rare diseases and their treatment for healthcare professionals and consumers. It was an honor and a profound responsibility, driving us to master the nuances of each condition and its impact on the lives of patients and loved ones.

With each passing year, we’re doing a better job of helping people suffering from rare diseases, but we could do better. It still takes too long to reach a proper diagnosis, for example. Personally, I love solving these challenges. I get especially excited when there is a therapy that helps patients live better.

I can’t help but think back to when I was 18 years old and recognized that my brother had a rare disease, that it was the beginning of a life and a career that would be so strongly focused on healthcare, with a passion for understanding and communicating about complicated diseases and drugs—especially rare ones.

Do you have a rare disease story? Is your company working towards a rare disease solution? I’d love to hear about it.

Let’s talk.

03/26/2024

"The BRANDMap™ approach sounds like the right one, especially in rare diseases! We all know that the 'last mile' between FDA approval and ensuring a new therapy is in the hands of everyone who needs it can be a long, expensive one if not done right. If you have a way to do it right (and fast) the first time, it will be great for patients and companies alike."

Glenna Crooks, CEO The Network Sage

03/21/2024

Janet Carlson is a master of insights, and she knows the rare disease space like the back of her hand. The BRANDMap™ is a process that would be extremely helpful to rare disease companies to ensure the marketing efforts reach the right audiences, at the right time, with the appropriate messaging. Highly recommend!​​​​​​​​​
Alec Lawson, Creative Director

www.111-group.com/pharma

03/05/2024

"The last mile between FDA approval and ensuring patients have the therapies can be complicated and expensive. Navigating that ‘last mile’ well is especially important for rare diseases. That’s because patients and their loved ones have often already suffered for many years and because most companies developing these therapies are small- and mid-size, without large industry players' staff and other resources. The good news is this: BRANDMap™ is a streamlined way to navigate with immense potential to be a game changer in traversing that last mile to benefit both patients and companies."​​​​​​​​​
Glenna Crooks, PhD, Awardee, Public Health Service Award for Exceptional Service in Orphan Products Development

Leave a comment or be in touch!

02/29/2024

On this Rare Disease Day, I have a request….​​​​​​​​​Are you a small/medium biopharmaceutical company focusing on rare diseases?
Do you know of one?
We’re looking for three small- to medium-sized companies focused on rare diseases to test a new way to optimize a rare disease product..
Spend 90 minutes with us in a structured interview, and we’ll:
• Outline your current situation and your future goals and map the path to get there.
• Profile tactical recommendations by lifecycle phase and by target audience.
• Recommend vendors who can deliver the plan.
Sound good?
(Oh, and if it matters to you, we and our partners are women-led, Veteran-led, and diverse – each working to their strengths. We know them, we can vouch for that, and we can save you money.)
Leave me a comment or be in touch!

02/29/2024

On this Rare Disease Day, I have a request….​​​​​​​​​Are you a small/medium biopharmaceutical company focusing on rare diseases?
Do you know of one?
We’re looking for three small- to medium-sized companies focused on rare diseases to test a new way to optimize a rare disease product..
Spend 90 minutes with us in a structured interview, and we’ll:
• Outline your current situation and your future goals and map the path to get there.
• Profile tactical recommendations by lifecycle phase and by target audience.
• Recommend vendors who can deliver the plan.
Sound good?
(Oh, and if it matters to you, we and our partners are women-led, Veteran-led, and diverse – each working to their strengths. We know them, we can vouch for that, and we can save you money.)
Leave me a comment or be in touch!
disease

02/29/2024

Embark on a transformative journey to shape your brand's success with BRANDMap™ as your strategic guide! But what exactly is BRANDMap? Picture it as your personalized roadmap, meticulously designed to navigate your brand from its current position to the desired destination. In a concise and insightful 90-minute structured interview, we delve into your present status and aspirations, crafting a tailored map that outlines the optimal route to your brand's success. To learn more, go to 111-group.com.